Genomic Vision Attended the 20th Edition of the European Drug Discovery Innovation Programme in Barcelona

Regulatory News:

Genomic Vision (FR0011799907 – GV, – the “Company”), a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, was delighted to take part in the 20^th Edition of the European Drug Discovery Innovation Programme held in Barcelona on September 12^th and 13^th.

This prominent event provided an invaluable opportunity for Genomic Vision's teams to reinforce a comprehensive understanding of customer demands in the quickly evolving pharmaceutical environment. It became evident that there is a very significant interest in artificial intelligence (AI) and machine learning (ML) within the drug discovery pipeline, highlighting their growing impact and importance in the industry.

During this event, Genomic Vision engaged in meaningful interactions, fostering new interested customer, and participating in professional discussions. The company had the privilege of attending several highly informative conferences on the subject of AI and ML in drug discovery. These sessions were fully in line with Genomic Vision's commitment to staying at the front of the technology advancements and positioning itself as a key player in this dynamic industry.

Indeed, Genomic Vision's innovative technology and its diverse range of applications are clearly associated with the evolving trends in biotechnology and the future of drug research. The company's participation in this event reaffirmed its dedication to facilitating advancements in drug discovery and enhancing the efficiency of pharmaceutical industry.

Yann BENUREAU, Senior Scientist at Genomic Vision, said: “This event gave us the opportunity to showcase our technology and observe the keen interest it has generated in the scientific community to shape the future of drug discovery. Our commitment to continuous adaptation and innovation remains unwavering as we strive to meet the evolving needs of our customers and the pharmaceutical industry as a whole.”

ABOUT THE EUROPEAN DRUG DISCOVERY INNOVATION PROGRAMME

The European Drug Discovery Innovation Programme is a prominent event in the field of pharmaceutical research in Europe. It brings together experts, researchers, and industry professionals to discuss the latest advancements, innovations and trends in drug discovery. This event provides a platform for knowledge exchange, professional networking, and thorough discussions on topics such as artificial intelligence, machine learning, and other technological advancements crucial to the future of pharmaceutical research. It represents a significant opportunity for companies and researchers to stay at the forefront of innovation and contribute to the ongoing improvement of medical treatments.